<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Mouse models have shown that interleukin (IL)6 stimulates survival, proliferation and progression to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of intestinal epithelial cells via activation of signal transducers and activators of transcription 3 (STAT3) </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To investigate the expression of IL6/phosphorylated STAT3 (p-STAT3)/suppressor of cytokine signalling 3 (SOCS3) in biopsy specimens from patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and UC-related <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) progression </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Biopsy specimens from patients with inactive UC (n=18), active UC (n=28), UC with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (LGD) (n=9), UC with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) (n=7), UC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (n=11) and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (n=14) were included </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsy specimens (n=9) from patients without colonic abnormalities served as control </plain></SENT>
<SENT sid="4" pm="."><plain>The protein expression of IL6, p-STAT3 and SOCS3 was determined immunohistochemically </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Patients with active UC had significantly more IL6 and p-STAT3-positive epithelial cells than both patients with inactive UC and controls (strong positive IL6: 53.6%, 11.1% and 0%, respectively; p-STAT3: 64.3%, 22.2% and 11.1%, respectively; <z:hpo ids='HP_0000001'>all</z:hpo> p&lt;or=0.012) </plain></SENT>
<SENT sid="6" pm="."><plain>SOCS3-positive cells were significantly increased in colonic epithelium of both inactive and active UC compared with controls (strong positive: 94.4%, 96.4% and 11.1%, respectively; both p&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, significantly more epithelial cells expressed IL6 and p-STAT3 compared with controls (strong positive IL6: 72.7% and 0% respectively; p-STAT3: 54.5% and 11.1%, respectively; both p&lt;0.05), whereas the proportion of SOCS3-positive cells in this progression reduced (LGD 33.3%; HGD 14.3%; UC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> 9.1%) </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, methylation of the SOCS3 gene was detected in epithelial cells from UC-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> biopsy specimens </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The importance of IL6/p-STAT3 in patients with <z:mp ids='MP_0001845'>inflammation</z:mp>-induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was demonstrated </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, SOCS3 may be involved in UC pathogenesis and the absence of SOCS3 seems critical for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression </plain></SENT>
</text></document>